Early Identification of Age-related Hearing Impairment

NCT ID: NCT06418321

Last Updated: 2025-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

49 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-04

Study Completion Date

2025-02-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The need for future hearing rehabilitation is enormous. World Health Organization (WHO 2021) has estimated that by 2050, 2.5 billion people will have some degree of hearing loss, and 1/4 of them will require hearing rehabilitation. Currently, healthcare systems and processes are already overwhelmed and not adequately equipped to screen and diagnose this rapidly growing population suffering from hearing impairment. This study aims to investigate if the diagnostics of age-related hearing loss can be accelerated by involving patients in the hearing assessment process.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigational device used in the study is part of the Otoscreen hearing screening system that is developed by Aalto University.

The investigational device consists of the following parts:

* Digital otoscope
* User interface control unit.

The investigational device is designed to record high-quality images and videos of the eardrum and ear canal and guide users through a hearing screening test while collecting data from questionnaires, digital otoscopy, and audiometry.

The investigational device is used together with a CE-marked audiometer that is intended for hearing screening testing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss, Age-Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participant group 1: HUS Helsinki University Hospital

Participants are tested with the investigational device and the gold-standard device.

Investigational device

Intervention Type DEVICE

The participants' hearing status will be evaluated using the investigational device.

Audiometer

Intervention Type OTHER

Participants' hearing thresholds are tested with an audiogram.

Otomicroscopy

Intervention Type DEVICE

The status of the participants' ear canals and tympanic membranes are checked.

REM (Real Ear Measurements)

Intervention Type OTHER

The acoustic properties of the participants' ears will be measured during the interventions.

Participant group 2: Aalto University

Participants are tested with the investigational device.

Investigational device

Intervention Type DEVICE

The participants' hearing status will be evaluated using the investigational device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Investigational device

The participants' hearing status will be evaluated using the investigational device.

Intervention Type DEVICE

Audiometer

Participants' hearing thresholds are tested with an audiogram.

Intervention Type OTHER

Otomicroscopy

The status of the participants' ear canals and tympanic membranes are checked.

Intervention Type DEVICE

REM (Real Ear Measurements)

The acoustic properties of the participants' ears will be measured during the interventions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Must be able to understand Finnish or Swedish

Exclusion Criteria

• Clinical diagnosis of hearing loss
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Business Finland

OTHER

Sponsor Role collaborator

Helsinki University Central Hospital

OTHER

Sponsor Role collaborator

Aalto University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jouni Partanen, Prof.

Role: PRINCIPAL_INVESTIGATOR

Aalto University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aalto University

Espoo, , Finland

Site Status

HUS Head and Neck Center

Helsinki, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

535/2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hear Again, Work Again
NCT05196022 RECRUITING
Hearing Loss in Older Adults Study
NCT03382769 TERMINATED NA
Hearing Program in Primary Care
NCT05943509 ACTIVE_NOT_RECRUITING NA